Medical Foam Market Report 2026

The medical foam market size has grown strongly in recent years. It will grow from $37.52 billion in 2025 to $41.26 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to increasing hospital bed capacity, rising prevalence of chronic wounds, growth in medical device manufacturing, adoption of foam-based cushioning solutions, expansion of healthcare infrastructure.

The medical foam market size is expected to see strong growth in the next few years. It will grow to $59.71 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing demand for advanced wound care products, rising focus on sustainable medical materials, expansion of home healthcare equipment usage, growing adoption of custom orthotic solutions, increasing investments in patient-centric medical products. Major trends in the forecast period include increasing demand for pressure-relief medical foams, growing use of antimicrobial foam materials, expansion of customized foam-based medical devices, rising adoption of lightweight and durable foam products, enhanced focus on patient comfort solutions.

The increasing prevalence of diabetes is expected to drive the growth of the medical foam market in the coming years. Diabetes is a chronic condition in which the body either does not produce sufficient insulin or cannot use the insulin effectively, resulting in elevated blood glucose levels that can lead to severe health complications if not properly managed. The rise in diabetes cases is attributed to sedentary lifestyles, unhealthy dietary habits, and the growing rates of obesity, while genetic factors and aging populations also contribute to the global increase in diabetes. Medical foam is used in diabetes care for wound management, particularly in treating diabetic ulcers, by providing a protective layer that absorbs exudate and supports healing. For example, in June 2024, the National Health Service, a publicly funded healthcare system in England, reported that 3,615,330 people registered with a GP were identified with non-diabetic hyperglycemia, also known as pre-diabetes, in 2023, compared to 3,065,825 in 2022, marking an increase of nearly 18%. Thus, the growing prevalence of diabetes is driving the medical foam market.

Major companies in the medical foam market are emphasizing the development of innovative materials, such as digital foam, to gain a competitive edge. Digital medical foam refers to advanced foam dressings embedded with digital sensors that monitor wound conditions in real time, improving wound care management. For example, in October 2023, EOS GmbH, a Germany-based provider of industrial 3D printing solutions, introduced the DIGITAL FOAM Architects Network. This initiative supports the design of customized foam structures with enhanced properties for medical applications, enabling the integration of smart technologies into foam products. It improves functionality in areas such as wound care and prosthetics, promoting innovation in the medical foam industry by providing tailored solutions to meet specific healthcare requirements.

In October 2024, UFP Technologies Inc., a US-based technology and custom manufacturing company, acquired AQF Medical Ltd. for an undisclosed amount. Through this acquisition, UFP Technologies aimed to strengthen its technological capabilities and expand its presence in the medical device supply chain by incorporating AQF Medical Ltd.’s specialized packaging and technical foam solutions. AQF Medical Ltd., based in Ireland, is a technology company that focuses on technical foam conversion and thermoplastic polyurethane (TPU) packaging solutions primarily for medical applications, including wound care, orthopedic packaging, and life-saving medical devices.

Major companies operating in the medical foam market are Bayer AG, 3M Company, Shin-Etsu Chemical Co. Ltd., Freudenberg Group, Avery Dennison Corp., Huntsman International LLC., Nitto Denko Corporation, Sonoco Products Company, FMC Biopolymer AS, Avient Corporation, Porex Corporation, Carpenter Co., FXI Holdings Inc., Rogers Corp., Armacell International Holding GmbH, Inoac Corporation, Future Foam, FoamPartner Group, General Plastics Manufacturing Company Inc., Recticel, Foamtec International, Technifoam.

North America was the largest region in the medical foam market in 2025. The regions covered in the medical foam market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical foam market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the medical foam market by increasing costs of imported polymers, chemical additives, processing equipment, and specialized foam production machinery. Medical product manufacturers in North America and Europe are most affected due to dependence on imported raw materials, while Asia-Pacific faces higher costs for export-oriented foam production. These tariffs are increasing manufacturing expenses and product pricing. However, they are also encouraging local sourcing of raw materials, regional foam production expansion, and innovation in alternative and sustainable medical foam formulations.

The medical foam market research report is one of a series of new reports that provides medical foam market statistics, including medical foam industry global market size, regional shares, competitors with a medical foam market share, detailed medical foam market segments, market trends and opportunities, and any further data you may need to thrive in the medical foam industry. This medical foam market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical foam is a specially formulated type of foam used in healthcare for cushioning, wound care, and support. It is designed to be durable, hypoallergenic, and often antimicrobial, offering comfort, pressure relief, and protection for patients. Medical foam finds application in products such as mattresses, padding for medical devices, dressings, and orthotic supports, aiding in patient care and recovery.

The primary types of medical foam include flexible foam, rigid foam, and spray foam. Flexible foam is soft and pliable, making it ideal for uses where comfort and cushioning are important. The various products include polyurethane (PU), polystyrene (PS), polyolefin, polyvinyl chloride (PVC), and others, and they are utilized in a range of applications such as bedding and cushioning, medical packaging, medical devices and components, prosthetics and wound care, among others.

The medical foam market consists of sales of pressure ulcer pads, ostomy seals, surgical positioning pads, prosthetic liners, and splint padding. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.